Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Operating Margin (2016 - 2025)

Historic Operating Margin for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to 168.46%.

  • Standard Biotools' Operating Margin fell 475800.0% to 168.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 86.93%, marking a year-over-year increase of 301600.0%. This contributed to the annual value of 100.46% for FY2024, which is 284300.0% down from last year.
  • Per Standard Biotools' latest filing, its Operating Margin stood at 168.46% for Q3 2025, which was down 475800.0% from 118.08% recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Operating Margin registered a high of 29.42% during Q4 2021, and its lowest value of 205.37% during Q2 2022.
  • Over the past 5 years, Standard Biotools' median Operating Margin value was 80.82% (recorded in 2025), while the average stood at 96.05%.
  • As far as peak fluctuations go, Standard Biotools' Operating Margin soared by 4230900bps in 2021, and later plummeted by -1497000bps in 2022.
  • Standard Biotools' Operating Margin (Quarter) stood at 29.42% in 2021, then plummeted by -166bps to 78.13% in 2022, then grew by 3bps to 75.87% in 2023, then increased by 10bps to 68.24% in 2024, then crashed by -147bps to 168.46% in 2025.
  • Its Operating Margin was 168.46% in Q3 2025, compared to 118.08% in Q2 2025 and 80.82% in Q1 2025.